Makristathis A, Pasching E, Schütze K, Wimmer M, Rotter M L, Hirschl A M
Department of Clinical Microbiology, Hygiene Institute of the University of Vienna, Vienna, Austria.
J Clin Microbiol. 1998 Sep;36(9):2772-4. doi: 10.1128/JCM.36.9.2772-2774.1998.
A highly sensitive seminested PCR assay to detect Helicobacter pylori DNA in feces was developed. PCR with stool specimens and a novel antigen enzyme immunoassay (EIA) for H. pylori detection in feces were evaluated as diagnostic tools and in follow-up with samples from 63 infected and 37 noninfected persons. Infected individuals received eradication therapy followed by endoscopic follow-up 35 days after the start of treatment. At that time, a second stool specimen was obtained from 55 of these patients. Before eradication, the sensitivity of PCR was 93.7% and that of EIA 88.9%. Specificities were 100 and 94.6%, respectively. Of the 55 follow-up specimens, 41 originated from patients from whom H. pylori had been eradicated. Of these, 21 were still positive by PCR and 13 were positive by EIA, indicating that 1 month may be too short a period for follow-up evaluation of stool specimens by these tests.
我们开发了一种用于检测粪便中幽门螺杆菌DNA的高灵敏度半巢式PCR检测方法。对粪便标本进行PCR以及用于粪便中幽门螺杆菌检测的新型抗原酶免疫测定(EIA)作为诊断工具,并对63名感染者和37名未感染者的样本进行随访。感染者接受根除治疗,治疗开始35天后进行内镜随访。此时,从其中55名患者处获取了第二份粪便标本。根除治疗前,PCR的灵敏度为93.7%,EIA的灵敏度为88.9%。特异性分别为100%和94.6%。在55份随访标本中,41份来自幽门螺杆菌已被根除的患者。其中,21份通过PCR仍呈阳性,13份通过EIA呈阳性,这表明对于这些检测而言,1个月的时间可能太短,无法对粪便标本进行随访评估。